On this episode of Stock Movers:
- Vestas Wind Systems jumped after the Danish wind developer said it is launching a new share buyback program of as much as €150 million ($172 million).
- Siemens Healthineers expects the impact from tariffs to roughly double to €400 million ($460 million) in fiscal 2026, according to Chief Financial Officer Jochen Schmitz.
- Novo Nordisk pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs Wegovy and Ozempic, underscoring the urgency facing its new chief executive.

On this episode of Stock Movers: - Vestas Wind Systems jumped after the Danish wind developer said it is launching a new share buyback program of as much as &euro;150 million ($172 million). - Siemens Healthineers expects the impact from tariffs to roughly double to &euro;400 million ($460 million) in fiscal 2026, according to Chief Financial Officer Jochen Schmitz. - Novo Nordisk pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs Wegovy and Ozempic, underscoring the urgency facing its new chief executive.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Vestas Jumps, Siemens Healthineers Dips, Novo Nordisk Up

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/89784b9f-b5dd-44e7-a0c7-b38c00977a0b/transcript

Advertisement